European Society of Hypertension

Home

European Society of Hypertension
European Society of Hypertension
History
The main purpose of the European Society of Hypertension (ESH) is to provide a stable and organised European platform for scientific exchange in hypertension. Professor Alberto Zanchetti and his colleagues initiated a series of European Hypertension Meetings in Milan in the years when the ISH did not hold any scientific meetings. Initially, these were organised without the help and support of a scientific society, except for the 1987 meeting which was organised under the endorsement and cooperation of ISH. The so-called “Milan Meetings” proved to be enormously successful, blending high-quality science and excellent organisation with a friendly academic atmosphere of the Milan University.

The Milan Meetings were very well-attended, perhaps because of the clear emphasis towards clinical hypertension research. The need for a European Society of Hypertension (ESH) was demonstrated by the success of the Milan Meetings, among other factors. The ESH was created in 1989. Thus, the 4th European Hypertension Meeting in Milan was the first to be organised under the auspices of the ESH. Much effort was given to make the ESH a true sister society of the ISH, and thus its by-laws and objectives were modeled after those of the ISH. Close cooperation between the two societies has existed since the ESH was first formed. For example, all European members of the ISH were automatically granted membership in the ESH, if desired. The Journal of Hypertension, the official journal of the ISH, was adopted by the ESH as its official journal.


ESH Scientific Council

President
Prof. Stéphane Laurent
Service de Pharmacologie et INSERM UMRS 872
Hôpital Européen Georges Pompidou
20 Rue Leblanc
75015 Paris - France

Vice President
Prof. Harry A.J. Struijker-Boudier
Cardiovascular Research Institute Maastricht
Universiteit Maastricht
P.O.Box 616
6200 MD Maastricht - The Netherlands

Contact Details

Prof. Krzysztof Narkiewicz - ESH Secretary
Dept. of Hypertension and Diabetology, Medical University of Gdansk
Debinki 7c, 80-952 Gdansk, Poland
Tel: +48 58 349 2527
Fax: +48 58 349 2601
contact: knark@amg.gda.pl
website: www.eshonline.org
Keywords:
hypertension, European, blood pressure, cardiovascular, treatment, European Society of Hypertension, ESH,

Related categories: Associations

ESH News

Hypertension News- Journal News

March 23, 2009
Source - Americam Journal of Hypertension
Argument - current smoking and hypertension risk
Hypertension risk decreased in current smokers…

March 20, 2009
Source - The Lancet
Argument - salt sensitivity
China: metabolic syndrome and salt sensitivity of BP in non-diabetic people

March 16, 2009
Source - Hypertension
Argument - Hypertension control
Hypertension management progresses in England, but room for improvement remains

March 13, 2009
Source - ASCOT
Argument - parental hypertension
Hypertension during pregnancy linked to future cardiovascular risk

March 9, 2009
Source - Hypertension
Argument- Sympathetic nerve activity
Sympathetic system overactive in hypertension-related left ventricular dysfunction

March 6, 2009
Source - International Journal of Cardiology
Argument - aldosterone
High aldosterone levels and stroke incidence in essential hypertensive patients

March 2, 2009
Source - Hypertension
Argument- ABPM
ABPM: mortality predictors in elderly with type 2 diabetes


For more news Click Here

To access guidelines Click Here

Membership

Membership for Physicians

Membership in the European Society of Hypertension is open to physicians who are scientifically active in hypertension research.
There are a number of benefits associated with the membership, such as continuous information from the Society by letters and by our new Internet Website.
Scientific meetings of the European Society are held annually in various cities around Europe, and on the ESH Internet Website you will find the upcoming events.
Importantly, ESH will also provide a programme for continuous professional education within hypertension. ESH is also actively promoting the new European Hypertension Specialist Programme

Those who are not members are urged to send (a) a list of academic degrees, professional positions, and publications (short CV), and (b) a written endorsement by two members of the ESH to the ESH Secretary (Prof. Krzysztof Narkiewicz, knark@amg.gda.pl) as early as possible (no later than MARCH 31, 2009). Applications will receive final approval by the Society at its annual scientific meeting in Milan in June 2009.

Kind regards.

Prof. Krzysztof Narkiewicz

ESH Secretary

Clinical Practice Newsletter


ESH Clinical Practice Newsletter
European Society of Hypertension

No. 36 Microalbuminuria in essential hypertension
No. 35 Statins and hypertension
No. 34 The microcirculation and the haemodynamics of hypertension
No. 33 Discovering the genetic determinants of hypertension
No. 32 Hypertension and Sexual Dysfunction
No. 31 Hypertension and Macrovascular Disease
No. 30 Hypertension and Heart Failure
No. 29 Treatment of High Blood Pressure in the Elderly
No. 28 Treatment of Hypertensive Urgencies and Emergencies
No. 27 Prevention of Type 2 Diabetes Mellitus with Antihypertensive Drugs
No. 26 Control of Hypertension in Patients with Peripheral Artery Disease
No. 25 Obstructive Sleep Apnea and Hypertension
No. 24 Hypertension and Arrhythmia
No. 23 Exercise and Hypertension
No. 22 High Blood Pressure, Alcohol and Cardiovascular Risk
No. 21 Treatment of Hypertension in Dialysed Patients
No. 20 High Blood Pressure, Smoking and Cardiovascular Risk
No. 19 Clinical Value of Ambulatory Blood Pressure Monitoring
No. 18 Beneficial Combinations of Two or More Antihypertensive Agents
No. 17 Interactions between Antihypertensive Agents and Other Drugs
No. 16 Microalbuminuria in Type-1 Diabetes Mellitus
No. 15 Resistant Hypertension
No. 14 Hypertension and Coronary Heart Disease
No. 13 Hypertension in Children and Adolescents
No. 12 Home Blood Pressure Monitoring
No. 11 Assessment of Preclinical Target Organ Damage in Hypertension: Carotid Intima-media Thickness and Plaque
No. 10 Hypertension and Left Ventricular Hypertrophy
No. 9 1999 WHO Hypertension Guidelines · Highlights and the ESH Update
No. 8 Cyclosporin-induced Hypertension
No. 7 Patient Compliance in the Treatment of Arterial Hypertension
No. 6 Isolated Systolic Hypertension
No. 5 How to Handle Renovascular Hypertension
No. 4 Hyertension and Chronic Renal Failure
No. 3 How Well is Hypertension Controlled in Europe?
No. 2 Hypertension in Pregnancy: Recommendations for Diagnosis and Treatment
No. 1 Treatment of Hypertension in Patients with Type-2 Diabetes Mellitus

ESH Hypertension Excellence Centres

Hypertension Excellence Centre

Approved ESH Hypertension Excellence Centres
In April 2007, the ESH Scientific Council has approved 65 centers in the first round of applicants, representing 13 European countries.

The list of ESH Hypertension Excellence Centers was published in the journals endorsed by the ESH (Journal of Hypertension and Blood Pressure) and displayed on the ESH Website (www.eshonline.org).

Official certificates were handed to the heads of these centers during the 17th European Meeting on Hypertension in Milan. New applications to become a Centre of Excellence received before December 31, 2007, were evaluated by the ESH Scientific Council in March 2008. Twenty two new centers from 14 countries were approved (see the list below). Heads of the ESH Centers of Excellence will be invited to a special workshop during the 2009 ESH Meeting in Milan.

Requirements and Application Form for Insitutes that wish to become ESH Hypertension Excellence Centres

The list of centres approved by the Board will be published annually in the Journal of Hypertension and Blood Pressure. Approved National Excellence Centres
Map of the ESH Hypertension Excellence Centres

Congresses and Events

Congress & Events

Future ESH Meetings
Copyright® 2010 Business Briefings, Ltd. All rights reserved.
Touch Cardiology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.